Arena Pharmaceuticals Inc - ARNA - and Eisai Inc. reported that the FDA has accepted for filing and review Arena’s resubmission of the New Drug Application for lorcaserin

Tags: ARNA LULU MTSN Nasdaq:ARNA Nasdaq:LULU Nasdaq:MTSN